Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Paganelli

Showing results (131-140 of 165) with videos related to

Pageof 17
Sort By:
British Journal of Cancer|January 26, 2000
Sentinel node biopsy in early vulvar cancerC De Cicco, M Sideri, M Bartolomei, et al.
Medical Physics|August 24, 2011
Calculation of electron and isotopes dose point kernels with FLUKA Monte Carlo code for dosimetry in nuclear medicine therapyF Botta, A Mairani, G Battistoni, et al.
Journal of Endocrinological Investigation|July 15, 2006
Carcinoid crisis induced by receptor radionuclide therapy with 90Y-DOTATOC in a case of liver metastases from bronchial neuroendocrine tumor (atypical carcinoid)M V Davì, L Bodei, G Francia, et al.
Cancer Biotherapy & Radiopharmaceuticals|July 27, 2001
Pre-targeted locoregional radioimmunotherapy with 90Y-biotin in glioma patients: phase I study and preliminary therapeutic resultsG Paganelli, M Bartolomei, M Ferrari, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1996
Quantitative comparison of direct antibody labeling and tumor pretargeting in uveal melanomaP Magnani, G Paganelli, G Modorati, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 27, 2020
Clinical value of negative <sup>68</sup>Ga-PSMA PET/CT in the management of biochemical recurrent prostate cancer patientsM Celli, U De Giorgi, P Caroli, et al.
Biopolymers|March 27, 2003
90Y-DOTA-D-Phe1-Try3-octreotide in therapy of neuroendocrine malignanciesG Paganelli, L Bodei, D Handkiewicz Junak, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 25, 2015
Measurement of circulating transcripts and gene cluster analysis predicts and defines therapeutic efficacy of peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumorsL Bodei, M Kidd, I M Modlin, et al.
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|July 13, 2002
Radioguided occult lesion localisation (ROLL) and surgical biopsy in breast cancer. Technical aspectsC De Cicco, M Pizzamiglio, G Trifirò, et al.
Nuclear Medicine Communications|October 21, 1999
Radiation protection in radioguided surgery of breast cancerM Cremonesi, M Ferrari, E Sacco, et al.
Pageof 17

Showing results (131-140 of 165) with videos related to

Sort By:
Pageof 17
British Journal of Cancer|January 26, 2000
Sentinel node biopsy in early vulvar cancerC De Cicco, M Sideri, M Bartolomei, et al.
Medical Physics|August 24, 2011
Calculation of electron and isotopes dose point kernels with FLUKA Monte Carlo code for dosimetry in nuclear medicine therapyF Botta, A Mairani, G Battistoni, et al.
Journal of Endocrinological Investigation|July 15, 2006
Carcinoid crisis induced by receptor radionuclide therapy with 90Y-DOTATOC in a case of liver metastases from bronchial neuroendocrine tumor (atypical carcinoid)M V Davì, L Bodei, G Francia, et al.
Cancer Biotherapy & Radiopharmaceuticals|July 27, 2001
Pre-targeted locoregional radioimmunotherapy with 90Y-biotin in glioma patients: phase I study and preliminary therapeutic resultsG Paganelli, M Bartolomei, M Ferrari, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1996
Quantitative comparison of direct antibody labeling and tumor pretargeting in uveal melanomaP Magnani, G Paganelli, G Modorati, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 27, 2020
Clinical value of negative <sup>68</sup>Ga-PSMA PET/CT in the management of biochemical recurrent prostate cancer patientsM Celli, U De Giorgi, P Caroli, et al.
Biopolymers|March 27, 2003
90Y-DOTA-D-Phe1-Try3-octreotide in therapy of neuroendocrine malignanciesG Paganelli, L Bodei, D Handkiewicz Junak, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 25, 2015
Measurement of circulating transcripts and gene cluster analysis predicts and defines therapeutic efficacy of peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumorsL Bodei, M Kidd, I M Modlin, et al.
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|July 13, 2002
Radioguided occult lesion localisation (ROLL) and surgical biopsy in breast cancer. Technical aspectsC De Cicco, M Pizzamiglio, G Trifirò, et al.
Nuclear Medicine Communications|October 21, 1999
Radiation protection in radioguided surgery of breast cancerM Cremonesi, M Ferrari, E Sacco, et al.
Pageof 17